Related Experiment Videos
Continuous long-term insulin delivery in diabetic rats utilizing implanted osmotic minipumps
Journal of Pharmacological Methods
|February 1, 1983
Summary
Continuous insulin delivery via osmotic minipumps showed no long-term advantage over daily injections for controlling diabetes in rats. Glucose control failed in most rats after seven days, indicating limited efficacy for this method.
Area of Science:
- Endocrinology
- Diabetology
- Pharmacology
Background:
- Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia.
- Effective insulin delivery is crucial for long-term diabetes management.
- Osmotic minipumps offer a potential method for continuous drug delivery.
Purpose of the Study:
- To evaluate the efficacy of surgically implanted osmotic minipumps for continuous insulin delivery in chemically-induced diabetic rats.
- To compare the long-term glucose control provided by osmotic minipumps versus daily insulin injections.
Main Methods:
- Chemically-induced diabetic rat model.
- Surgical implantation of insulin-filled osmotic minipumps.
- Monitoring of serum glucose levels over a 31-day study period.
Main Results:
- Osmotic minipumps maintained normal serum glucose levels for the initial 7 days in all diabetic rats.
- Inadequate glucose control was observed in over 50% of rats after 7 days.
- Only 7 out of 20 rats achieved adequate glucose control throughout the 31-day study.
Conclusions:
- Insulin-filled osmotic minipumps do not offer a significant advantage over daily insulin injections for long-term diabetes control in this rat model.
- The efficacy of osmotic minipumps for continuous insulin delivery is limited beyond the initial 7-day period.